Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy Study of RTS,S AS02A/AS01B Vaccine to Prevent Malaria

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1/PHASE2
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Be in good general health~* Be able to participate for 4-15 months~Exclusion Criteria:~* Pregnant or planning pregnancy~* History of malaria or exposure to malaria in past 12 months~* Received an investigational malaria vaccine~* Past history of allergic reaction to previous immunization~* Positive blood tests for HIV and specific types of hepatitis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).